Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print 3-drug combination 'extremely promising' as first-line therapy for multiple myeloma
Slashdot It! Slashdot 3-drug combination 'extremely promising' as first-line therapy for multiple myeloma
Submit to Reddit Submit 3-drug combination 'extremely promising' as first-line therapy for multiple myeloma to Reddit
Reading: 3-drug combination 'extremely promising' as first-line therapy for multiple myelomaTwitter This Reading: 3-drug combination 'extremely promising' as first-line therapy for multiple myelomaTwitter 3-drug combination 'extremely promising' as first-line therapy for multiple myeloma
Add to Facebook Add 3-drug combination 'extremely promising' as first-line therapy for multiple myeloma to Facebook

3-drug combination 'extremely promising' as first-line therapy for multiple myeloma

December 12, 2007

ATLANTA-A new combination of bortezomib (Velcade) and two other drugs is showing a very high response rate in patients newly diagnosed with multiple myeloma, a team headed by Dana-Farber Cancer Institute investigators reported at the annual meeting of the American Society of Hematology.

The three-pronged regimen of Velcade, lenalidomide (Revlimid) and dexamethasone - referred to as Rev/Vel/Dex - has achieved an overall response rate of 98 percent in 42 patients evaluated thus far in a Phase 1-2 trial, said Paul Richardson, MD, of Dana-Farber and the study's principal investigator. He added that 52 percent of the patients had high quality responses (very good partial response or better), with 30 percent achieving complete response to date.




"These may be some of the best response rates we've seen to date with up-front therapies, and although these are preliminary results, they are extremely promising," Richardson said. The patients were previously untreated when they received the Rev/Vel/Dex combination.

Velcade is a "smart" drug known as a proteasome inhibitor that blocks the myeloma cells' waste disposal system, creating an accumulation of toxic compounds that poison the cell. Revlimid is a chemical relative of thalidomide that affects several pathways in cancer cells, including immune mechanisms and blood vessel growth to tumors. Dexamethasone is a steroid hormone that counters inflammation and is used to treat hematologic malignancies such as myeloma. Studies leading to the trial of the three drugs in combination were carried out at Dana-Farber.

While these are the first results from trials of Rev/Vel/Dex given as initial, first-line therapy for the blood cancer, the combination has already been shown effective for multiple myeloma patients who had relapsed following successful treatment or who had not responded to standard therapies.

Richardson also reported at the ASH meeting preliminary data from a Dana-Farber led multicenter Phase 2 trial of the combination in relapsed or refractory myeloma. "These data confirm the favorable side effect profile," said Richardson, "and the response rate of 72 percent - including complete, partial, and minor responses - is very encouraging."

The responses, he added, appear to be holding up well, with a duration of more than one year for some patients to date. Both trials will continue to enroll patients, and final results are expected next year.

Dana-Farber Cancer Institute





Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
AIDS   Butterflies   Cryoablation   Appendicitis   Meteorites   MRSA   Exercise   Secondhand Smoke   Ovarian Cancer   Caesarean   Autoimmune Diseases   Air Quality   Sleep Disorders   Nausea   Embryonic Development   Yeast Cells   Neurodegeneration   Honey Bee   Cardiomyopathy   Mental Illness   Amazon rainforest   Pheromones   Miscarriage   Stroke Risk   Quarks  
Related Multiple Myeloma Current Events and Multiple Myeloma News Articles Multiple Myeloma Current Events and Multiple Myeloma News RSS Multiple Myeloma Current Events and Multiple Myeloma News RSS
Individuals who apply pesticides are found to have double the risk of blood disorder
A study involving 678 individuals who apply pesticides, culled from a U.S. Agricultural Health Study of over 50,000 farmers, recently found that exposure to certain pesticides doubles one's risk of developing an abnormal blood condition called MGUS (monoclonal gammopathy of undetermined significance) compared with individuals in the general population.

X-rays help predict permanent bone damage from bisphosphonates
Breast cancer patients, individuals at risk for osteoporosis and those undergoing certain types of bone cancer therapies often take drugs containing bisphosphonates.

Scientists identify key gene that protects against leukemia
Researchers have identified a gene that controls the rapid production and differentiation of the stem cells that produce all blood cell types-a discovery that could eventually open the door to more streamlined treatments for leukemia and other blood cancers, in which blood cells proliferate out of control.

Getting down to cancer basics
Researchers have identified a new cancer gene - one that is common to many cancers and affects the most basic regulation of our genes. The new example - a gene on the X chromosome called UTX - is found in 10% of cases of multiple myeloma and 8% of esophageal cancers.

Search reveals molecules that block Stat 3
Finding molecules that block the activity of the oncogene Stat3 (signal transducer and activator of transcription) required screening literally millions of compounds, using computers that compared the structure of the cancer-causing gene to those of the small molecules, said a Baylor College of Medicine researcher in a report that appears in the current online issue of the journal PLoS One (Public Library of Science ONE).

Protein helps immune cells to divide and conquer
Researchers at the University of California, San Diego School of Medicine have identified a key protein that is required for immune cells called B lymphocytes to divide and replicate themselves. The rapid generation of large numbers of these immune cells is critical to the body's antibody defense mechanism.

USC study finds that green tea blocks benefits of cancer drug
Contrary to popular assumptions about the health benefits of green tea, researchers at the University of Southern California (USC) have found that the widely used supplement renders a cancer drug used to treat multiple myeloma and mantle cell lymphoma completely ineffective in treating cancer.

Cancer drug effectively treats transplant rejections
University of Cincinnati (UC) researchers have discovered a new therapy for transplant patients, targeting the antibody-producing plasma cells that can cause organ rejection.

Promising results from 2 trials highlighting pomalidomide presented at ASH
Celgene International Sarl (Nasdaq: CELG) today announced that its next IMiDs compound, pomalidomide, has shown promising activity with manageable safety and tolerability for the treatment of relapsed/refractory multiple myeloma (MM) and myelofibrosis.

Analysis shows revlimid plus dexamethasone increases overall survival in multiple myeloma patients
Celgene International Sarl (NASDAQ: CELG) announced that data from a landmark analysis of patients with relapsed/refractory multiple myeloma found that continuous treatment with REVLIMID (lenalidomide) in combination with dexamethasone after achieving best response resulted in significantly longer overall survival and increased time to disease progression compared to those who discontinued treatment after ten months or less.
More Multiple Myeloma Current Events and Multiple Myeloma News Articles
Multiple Myeloma: The Plain English Handbook for Patients and Care Givers

Multiple Myeloma: The Plain English Handbook for Patients and Care Givers
by Robert, J Heller (Author)

A concise and helpful overview of the disease, including therapies, medications, problems, and lifestyle changes. Many helpful hints in an easy to understand format which avoids a lot of hard to understand terminology in favor of a more light-hearted approach. Includes reproducible forms and many references to other sources.

100 Questions and Answers About Myeloma (100 Questions & Answers about . . .)

100 Questions and Answers About Myeloma (100 Questions & Answers about . . .)
by Asad Bashey (Author), Rafat Abonour (Author)

Whether you are a newly diagnosed myeloma patient, a survivor, or a friend or relative of either, this book offers help. The only text to provide the doctor s and patient s views, 100 Questions & Answers About Myeloma gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. Written by a hematologist-oncologist specializing in myeloma treatment, and featuring insider advice from an actual patient, this book is an invaluable resource for anyone coping with the physical and emotional turmoil of this frightening disease.

Treatment of Multiple Myeloma and Related Disorders

Treatment of Multiple Myeloma and Related Disorders
by S. Vincent Rajkumar (Editor), Robert A. Kyle (Editor)

Due to major advances in understanding the biology and pathogenesis of the disease, the management of multiple myeloma is changing rapidly. New diagnostic and prognostic criteria have been introduced, and treatment options are multiplying with high-dose chemotherapy regimens, stem cell transplants, and the development of novel agents and immune-based strategies that target tumor cells directly. This book is aimed at the practitioner who is looking to put these advances into clinical context. It will serve as an up-to-date resource for treatment of myeloma and related disorders. Chapters are written by international authorities and contain color photos, diagrams, and algorithms outlining preferred treatment strategies. Relevant scientific information is integrated throughout, but the...

Treatment of Multiple Myeloma and Related Disorders

Treatment of Multiple Myeloma and Related Disorders
by Cambridge University Press

Due to major advances in understanding the biology and pathogenesis of the disease, the management of multiple myeloma is changing rapidly. New diagnostic and prognostic criteria have been introduced, and treatment options are multiplying with high-dose chemotherapy regimens, stem cell transplants, and the development of novel agents and immune-based strategies that target tumor cells directly. This book is aimed at the practitioner who is looking to put these advances into clinical context. It will serve as an up-to-date resource for treatment of myeloma and related disorders. Chapters are written by international authorities and contain color photos, diagrams, and algorithms outlining preferred treatment strategies. Relevant scientific information is integrated throughout, but the...

  Multiple Myeloma: Translational and Emerging Therapies
by Kenneth C. Anderson (Author)

Multiple myeloma is the second most prevalent hematological malignancy, with over 55,000 new cases diagnosed each year. This exciting new text, edited by lauded authorities on the topic, stands as the only available reference to assemble, review, and synthesize the latest studies on translational therapies, and clearly explains the impact of molecular pathogenesis, biology, and prognostic factors on the diagnosis, prognosis, and individualization of treatment and the development of novel therapeutic options for patients with myeloma. Moving from the bench to the bedside to the forefront of therapeutic development, this source: helps clinicians and researchers effectively deploy therapeutic strategies into clinical practice reflects trends in the use of agents which target both the...

Multiple Myeloma Medical Guide

Multiple Myeloma Medical Guide
by Qontro Medical Guides (Author)

The Multiple Myeloma Medical Guide is a publication which has been designed to better help readers understand Multiple Myeloma. This Qontro Medical Guide has been designed with the reader in mind, and is a useful information source for readers at all levels looking to learn more about Multiple Myeloma. The Multiple Myeloma Medical Guide is highly recommended for those interested in understanding and learning more about Multiple Myeloma.

Clearly Charming Burgundy Ribbon - Multiple Myeloma Awareness Italian Charm 18k Gold and Enamel by Casa D'Oro

Clearly Charming Burgundy Ribbon - Multiple Myeloma Awareness Italian Charm 18k Gold and Enamel by Casa D'Oro

Show your support for those people who are affected and for a cure. This charm is made by Casa D'Oro with 18k gold and baked enamel. It will make a great addition to your Italian charm bracelet or a perfect personalized gift. Commemorate special occasions, capture memorable moments, or simply show support for those affected by creating your own original Italian charm bracelet. Add Clearly Charming premium quality interlocking modular Italian charm links to your Italian Charm Bracelet and create your own memory bracelet.

2009 Conquering Cancer - The Empowered Patient's Complete Reference to Multiple Myeloma and Plasma Cell Neoplasms - Diagnosis, Treatment Options, Prognosis (Two CD-ROM Set)

2009 Conquering Cancer - The Empowered Patient's Complete Reference to Multiple Myeloma and Plasma Cell Neoplasms - Diagnosis, Treatment Options, Prognosis (Two CD-ROM Set)
by PM Medical Health News (Author)

This up-to-date and comprehensive set of two CD-ROM discs provides a superb collection of official Federal government documents on multiple myeloma and plasma cell neoplasms: signs and symptoms, diagnosis, lab tests, treatment and management options, and ongoing clinical research. Every aspect of the disease is thoroughly covered. Multiple myeloma is a type of cancer that begins in plasma cells (white blood cells that produce antibodies). It is also called Kahler disease, myelomatosis, and plasma cell myeloma. Coverage includes treatment options, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy. For patients, practical information is provided in clearly written patient education documents. For medical professionals, doctor references and texts have...

Beating Multiple Myeloma/Plasma Cell Neoplasm Together Sweatshirt Large White

Beating Multiple Myeloma/Plasma Cell Neoplasm Together Sweatshirt Large White



Multiple Myeloma Awareness Ribbon Mouse Pad

Multiple Myeloma Awareness Ribbon Mouse Pad
by MyHeritageWear.com

The Multiple Myeloma Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Multiple Myeloma Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Multiple Myeloma Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness!

© 2009 BrightSurf.com